German (DAX) Life Sciences Industry Analysis

UpdatedFeb 08, 2026

DataAggregated Company Financials

Companies6

7D1.1%
3M4.1%
1Y-19.4%
YTD-2.8%

In the last week, the Life Sciences industry is up 1.1%, with Gerresheimer up 1.7%. However, the industry is down 19% over the past year. Looking forward, earnings are forecast to grow by 24% annually.

Industry Valuation and Performance

Has the German Life Sciences Industry valuation changed over the past few years?

Date	Market Cap	Revenue	Earnings	PE	Absolute PE	PS
Sun, 08 Feb 2026	€18.9b	€7.5b	€143.5m	38x	131.6x	2.5x
Tue, 06 Jan 2026	€19.8b	€7.5b	€143.5m	41.1x	138.2x	2.6x
Thu, 04 Dec 2025	€20.6b	€7.5b	€143.9m	38.6x	142.8x	2.7x
Sat, 01 Nov 2025	€20.0b	€7.5b	€147.4m	40.8x	135.4x	2.7x
Mon, 29 Sep 2025	€17.5b	€7.4b	€157.8m	21x	111x	2.4x
Wed, 27 Aug 2025	€18.4b	€7.4b	€157.8m	24x	116.9x	2.5x
Fri, 25 Jul 2025	€19.0b	€7.4b	€108.0m	26.4x	175.6x	2.6x
Sun, 22 Jun 2025	€20.2b	€7.3b	€114.9m	27.9x	175.5x	2.8x
Tue, 20 May 2025	€21.7b	€7.3b	€114.9m	27.6x	189.3x	3x
Thu, 17 Apr 2025	€19.7b	€7.3b	€137.1m	25.5x	143.5x	2.7x
Sat, 15 Mar 2025	€22.2b	€7.1b	€156.5m	26.8x	141.8x	3.1x
Mon, 10 Feb 2025	€23.5b	€7.1b	€169.8m	24.2x	138.4x	3.3x
Wed, 08 Jan 2025	€22.4b	€7.1b	€169.8m	25.8x	131.9x	3.2x
Fri, 06 Dec 2024	€21.5b	€7.1b	€170.5m	26.5x	125.8x	3x
Sun, 03 Nov 2024	€23.5b	€7.1b	€171.2m	29.7x	137.3x	3.3x
Tue, 01 Oct 2024	€24.2b	€7.1b	€172.8m	30.7x	139.9x	3.4x
Thu, 29 Aug 2024	€24.3b	€7.0b	€157.1m	36x	154.9x	3.5x
Sat, 27 Jul 2024	€24.8b	€7.0b	€237.1m	36x	104.6x	3.5x
Mon, 24 Jun 2024	€22.5b	€7.0b	€333.3m	28.1x	67.4x	3.2x
Wed, 22 May 2024	€26.3b	€7.0b	€340.1m	29.3x	77.5x	3.8x
Fri, 19 Apr 2024	€28.4b	€7.0b	€329.0m	35.8x	86.2x	4x
Sun, 17 Mar 2024	€34.1b	€7.1b	€384.5m	38.5x	88.6x	4.8x
Tue, 13 Feb 2024	€32.5b	€7.3b	€516.3m	38.9x	62.9x	4.5x
Thu, 11 Jan 2024	€30.8b	€7.3b	€507.1m	35.5x	60.7x	4.2x
Sat, 09 Dec 2023	€29.4b	€7.3b	€507.1m	31.7x	57.9x	4x
Mon, 06 Nov 2023	€26.3b	€6.4b	€356.1m	39.4x	74x	4.1x
Wed, 04 Oct 2023	€26.0b	€6.6b	€498.1m	37.3x	52.2x	3.9x
Fri, 01 Sep 2023	€31.2b	€6.6b	€498.1m	45.5x	62.6x	4.7x
Sun, 30 Jul 2023	€30.6b	€6.6b	€425.8m	42.8x	71.8x	4.7x
Tue, 27 Jun 2023	€26.5b	€6.7b	€487.3m	37.3x	54.3x	3.9x
Thu, 25 May 2023	€27.1b	€6.7b	€487.3m	37.2x	55.7x	4x
Sat, 22 Apr 2023	€27.9b	€6.8b	€595.6m	33.3x	46.8x	4.1x
Mon, 20 Mar 2023	€30.0b	€6.7b	€594.3m	33.9x	50.4x	4.5x
Wed, 15 Feb 2023	€32.6b	€6.5b	€447.4m	40.5x	72.9x	5x

Price to Earnings Ratio

72.9x

Wed, 15 Feb 2023

Current Industry PE

Investors are optimistic on the German Life Sciences industry, and appear confident in long term growth rates.

The industry is trading at a PE ratio of 132x which is higher than its 3-year average PE of 105x.

The 3-year average PS ratio of 3.5x is higher than the industry's current PS ratio of 2.5x.

Past Earnings Growth

The earnings for companies in the Life Sciences industry have declined 32% per year over the last three years.
Meanwhile revenues for these companies have grown 5.2% per year.
This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.